Drug Profile
BILA 2157 BS
Alternative Names: BILA 2157Latest Information Update: 16 Oct 2003
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim (Canada)
- Class Antihypertensives
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension